NO20003956L - Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten - Google Patents

Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten

Info

Publication number
NO20003956L
NO20003956L NO20003956A NO20003956A NO20003956L NO 20003956 L NO20003956 L NO 20003956L NO 20003956 A NO20003956 A NO 20003956A NO 20003956 A NO20003956 A NO 20003956A NO 20003956 L NO20003956 L NO 20003956L
Authority
NO
Norway
Prior art keywords
loop
vector containing
adenovirus vector
peptide epitope
heterologous peptide
Prior art date
Application number
NO20003956A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003956D0 (no
Inventor
David T Curiel
Victor N Krasnykh
Igor Dmitriev
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of NO20003956D0 publication Critical patent/NO20003956D0/no
Publication of NO20003956L publication Critical patent/NO20003956L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20003956A 1998-02-06 2000-08-04 Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten NO20003956L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7394798P 1998-02-06 1998-02-06
US9980198P 1998-09-10 1998-09-10
PCT/US1999/002549 WO1999039734A1 (fr) 1998-02-06 1999-02-05 Vecteur adenoviral contenant un epitope peptidique heterologue dans la boucle hi du bouton de fibre

Publications (2)

Publication Number Publication Date
NO20003956D0 NO20003956D0 (no) 2000-08-04
NO20003956L true NO20003956L (no) 2000-10-05

Family

ID=26755086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003956A NO20003956L (no) 1998-02-06 2000-08-04 Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten

Country Status (11)

Country Link
US (1) US7297542B2 (fr)
EP (1) EP1053013A4 (fr)
JP (1) JP2002507391A (fr)
KR (1) KR20010034487A (fr)
CN (1) CN1304316A (fr)
AU (1) AU744252B2 (fr)
BR (1) BR9908613A (fr)
CA (1) CA2327545A1 (fr)
IL (1) IL137681A0 (fr)
NO (1) NO20003956L (fr)
WO (1) WO1999039734A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395875B1 (en) * 1999-01-25 2002-05-28 Brookhaven Science Associates Llc Recombinant soluble adenovirus receptor
US7157266B2 (en) * 1999-01-25 2007-01-02 Brookhaven Science Associates Llc Structure of adenovirus bound to cellular receptor car
JP2003514577A (ja) 1999-11-25 2003-04-22 トランジェーヌ、ソシエテ、アノニム 改変アデノウイルス繊維および使用
EP1272507B1 (fr) 2000-04-12 2005-06-29 Amersham Health AS Composes a base de peptides
JP3635462B2 (ja) 2000-05-31 2005-04-06 国立医薬品食品衛生研究所長 アデノウイルスベクター
US6849446B2 (en) 2000-05-31 2005-02-01 University Of Saskatchewan Modified bovine adenovirus having altered tropism
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
NZ530156A (en) 2001-07-10 2007-04-27 Ge Healthcare As Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents
US9175309B2 (en) 2001-09-29 2015-11-03 Industry-University Cooperation Foundation Hanyang University Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
WO2004007537A2 (fr) * 2002-07-10 2004-01-22 Transgene S.A. Fibre d'adenovirus modifiee incapable de se lier aux recepteurs cellulaires contenant du glycosaminoglycane ou de l'acide sialique
WO2005027711A2 (fr) * 2003-05-01 2005-03-31 University Of Washington Vecteurs d'adenovirus a capside modifiee et methodes d'utilisation
AU2004238979B2 (en) * 2003-05-14 2008-12-18 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Broadening adenovirus tropism
US20070104732A1 (en) * 2003-10-24 2007-05-10 Bernard Massie Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
US8518228B2 (en) 2011-05-20 2013-08-27 The University Of British Columbia Systems and methods for enhanced SCODA
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US9186685B2 (en) 2012-01-13 2015-11-17 The University Of British Columbia Multiple arm apparatus and methods for separation of particles
CA2552262C (fr) 2004-02-02 2016-04-19 The University Of British Columbia Scodaphorese, procedes et appareil utilises pour deplacer et concentrer des particules
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
US7473418B2 (en) 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
DE102004021584A1 (de) * 2004-05-03 2005-12-01 Stefan Kochanek Modifizierte virale Vektorpartikel
US7776322B2 (en) 2004-08-16 2010-08-17 Stefan Kochanek Modified viral vector particles
CA2496294A1 (fr) * 2005-02-07 2006-08-07 The University Of British Columbia Appareil et methodes pour concentrer et separer des particules comme des molecules
CA2646671A1 (fr) 2006-03-30 2007-11-01 University Of California Procedes et compositions de secretion localisee d'anticorps anti-ctla-4
US7919079B2 (en) 2006-03-31 2011-04-05 Biosante Pharmaceuticals, Inc. Cancer immunotherapy compositions and methods of use
US20100272753A1 (en) * 2006-10-26 2010-10-28 The Johns Hopkins University Recombinant Adenovirus Vaccines
US8475641B2 (en) * 2008-02-01 2013-07-02 The University Of British Columbia Methods and apparatus for particle introduction and recovery
WO2009137211A2 (fr) * 2008-05-04 2009-11-12 University Of Maryland Biotechnology Institute Off. Of Research Admin./ Tech. Dev. Ensembles fibreux pour une présentation d'anticorps, et analyse antigénique multiplexée les utilisant
CN102265158A (zh) 2008-12-23 2011-11-30 通用电气健康护理有限公司 99mTc肽基化合物作为骨髓成像剂的应用
WO2010121381A1 (fr) 2009-04-21 2010-10-28 The University Of British Columbia Système et procédés pour la détection de particules
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
WO2012006145A2 (fr) * 2010-06-29 2012-01-12 The Johns Hopkins University Compositions et procédés pour le reciblage de constructions virales
US9267153B2 (en) * 2011-12-15 2016-02-23 Washington University Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
EP2825649B1 (fr) * 2012-03-13 2019-07-31 The Salk Institute for Biological Studies Ciblage cellulaire sélectif à l'aide d'adénovirus et de dimères chimiques
WO2013166444A2 (fr) 2012-05-04 2013-11-07 Boreal Genomics Corp. Analyse de biomarqueurs utilisant la scodaphorèse
WO2014153204A1 (fr) 2013-03-14 2014-09-25 Salk Institute For Biological Studies Compositions d'adénovirus oncolytiques
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
CN104634978A (zh) * 2013-11-13 2015-05-20 长春百克生物科技股份公司 一种分型检测腺病毒中和抗体的方法以及用于分型检测腺病毒中和抗体的试剂盒
CA2959130A1 (fr) * 2014-08-11 2016-02-18 The Board Of Regents Of The University Of Texas System Prevention de la dystrophie musculaire par edition de gene mediee par crispr/cas9
US11130986B2 (en) 2015-05-20 2021-09-28 Quantum-Si Incorporated Method for isolating target nucleic acid using heteroduplex binding proteins
JP7015551B2 (ja) 2016-02-23 2022-02-15 ソーク インスティテュート フォー バイオロジカル スタディーズ ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
JP7054527B2 (ja) 2016-02-23 2022-04-14 ソーク インスティテュート フォー バイオロジカル スタディーズ アデノウイルスの複製動態を測定するための高スループットアッセイ
WO2018111767A1 (fr) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Adénovirus synthétiques ciblant une tumeur et leurs utilisations
EP3565578A1 (fr) 2016-12-21 2019-11-13 Memgen LLC Adénovirus oncolytiques armés aptes à la réplication
WO2019006043A1 (fr) 2017-06-27 2019-01-03 Regeneron Pharmaceuticals, Inc. Vecteurs viraux recombinés à tropisme modifié et utilisations associées pour l'introduction ciblée de matériel génétique dans des cellules humaines
EP3927833A4 (fr) 2019-02-21 2022-11-30 Unleash Immuno Oncolytics, Inc. Vecteur adénoviral oncolytique et procédés d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
EP0866721A4 (fr) * 1995-12-08 2003-06-04 Univ Alabama Birmingham Res Fo Vecteurs adenoviraux cibles
WO2000067576A1 (fr) * 1999-05-12 2000-11-16 The Uab Research Foundation Adenovirus a pouvoir infectant renforce et a replication conditionnelle, et applications de celui-ci

Also Published As

Publication number Publication date
AU744252B2 (en) 2002-02-21
IL137681A0 (en) 2001-10-31
JP2002507391A (ja) 2002-03-12
AU2659599A (en) 1999-08-23
EP1053013A1 (fr) 2000-11-22
KR20010034487A (ko) 2001-04-25
CA2327545A1 (fr) 1999-08-12
US7297542B2 (en) 2007-11-20
NO20003956D0 (no) 2000-08-04
EP1053013A4 (fr) 2004-12-22
CN1304316A (zh) 2001-07-18
US20020081280A1 (en) 2002-06-27
BR9908613A (pt) 2000-10-31
WO1999039734A1 (fr) 1999-08-12

Similar Documents

Publication Publication Date Title
NO20003956L (no) Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten
DE69422632D1 (de) Antigen enthaltende nicht-ionische Tensid Vesikel
DE69833503D1 (de) Mechanismus der unterbrechung von bestimmungsortredirektion ausführt
FI930836A0 (fi) Topiska preparat som innehaoller cyklosporin
DE69835976D1 (de) Polarisationsunabhängiger optischer Phasenmodulator
FI924982A0 (fi) Frystorkat preparat som innehaoller monoklonal motkropp
DE69711715T2 (de) Anregungsvektorerzeugung
NO20006056D0 (no) Optiske fiberbånd som inneholder strålingsherdede innkapslingsmaterialer
DK12893D0 (da) Fremgangsmaade til fremstilling af normal saavel som ultrafin cement
DK0813876T3 (da) Cyclosporinholdigt præparat i form af en blød kapsel
FI925246A0 (fi) Fluorerade aldoketendimerer och deras anvaendning som kombinerade olje och vatten resistenta lim foer cellulosa material
DK0940712T3 (da) Projektionsskræm
DE69521163T2 (de) Optischer Halbleitermodulator
ID23159A (id) Wafer dan pembuatannya
FI933022A0 (fi) Radiosystem som bildar en traodloes lokalslinga
DE69710165D1 (de) Phasenregelschleife
DE69817897D1 (de) Phasenregelkreis
DE19881428D2 (de) Lustiges Gyros-Spielzeug
FR2767634B1 (fr) Godet desileur
ZA200003905B (en) Adenovirus Vector containing A Heterologous Peptide Epitope in the HI Loop of the Fiber Knob.
DE29610760U1 (de) Eimer-Container
FI973491A0 (fi) Markeringsmaolning och distributionsfoerpackning som anvaender en laogtrycksbehaollare foer densamma
FI963615A (fi) Peptidit, jotka estävät pepsiinin vapautumisen
FR2759536B1 (fr) Godet desileur
FI973017A0 (fi) Vedeldad bastuugn som uppvaermer vatten i tryckvattennaet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application